Prostate

Specific Antigen (PSA) Prostate Specific Antigen (PSA) is a protein produced in the prostate gland in males. It is used to screen for prostate cancer, as PSA levels that are higher than normal may suggest that a person has prostate cancer. PSA testing is conducted as part of a physical examination and is an important tool in diagnosing and managing prostate cancer, as well as other prostate-related conditions. It is also used to monitor the progress of treatments for prostate cancer, such as radiation therapy or hormone therapy. PSA testing is a safe and reliable way to detect potential prostate cancer and should be done regularly to ensure that any potential issues are addressed in a timely manner.

← Journal of Nephrology Advances

Related Articles

7 article(s) found

Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression

Full-text HTML Download PDF Download XML

The Bromine, Calcium, Potassium, Magnesium, Manganese, and Sodium Contents in Adenocarcinoma of Human Prostate Gland

Full-text HTML Download PDF Download XML

Markers for Significant or High-Grade Prostate Cancer in Patients over 75 Years Undergoing Prostatic Biopsy

Full-text HTML Download PDF Download XML

D Allele and DD Genotype of I /D Polymorphism in The ACE Gene in Patients with Hypertension, Stroke And Cancer Prostate In Libreville: A Concern Given The High Frequencies of these Signatures in Gabonese Population

Full-text HTML Download PDF Download XML

Using Prostatic Fluid Levels of Zinc to Bromine Concentration Ratio in Non-Invasive and Highly Accurate Screening for Prostate Cancer

Full-text HTML Download PDF Download XML

Pure Small Cell Carcinoma of Prostate in a Patient Presenting with Acute Urinary Retention: A Rare Case Report

Full-text HTML Download PDF Download XML

A Systematic Review of the Antimony Content of the Normal Human Prostate Gland

Full-text HTML Download PDF Download XML